Valluvan Jeevanandam

Valluvan Jeevanandam practices at Comer Children's Hospital - Hyde Park in Chicago, Illinois.

Valluvan Jeevanandam's NPI, 1285738344, was assigned on September 11, 2006. Valluvan Jeevanandam graduated from Vagelos College of Physicians and Surgeons in 1984. Valluvan Jeevanandam holds Illinois license 036098867.

Valluvan Jeevanandam's primary practice is Comer Children's Hospital - Hyde Park, at 5721 S Maryland Ave, Chicago, IL 60637 in Cook County. The practice phone is (773) 702-1530.

Valluvan Jeevanandam's primary practice is Comer Children's Hospital - Hyde Park in Chicago, Illinois. Valluvan Jeevanandam is also affiliated with University of Chicago Medical Center. The medical group on file is Endeavor Health Medical Group. Dmand AI also links Valluvan Jeevanandam to 4 more medical groups and 3 home health agencies, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Valluvan Jeevanandam practices, 4 sites in all. Vendor and product names are available with a free account.

Thoracic surgery (cardiothoracic vascular surgery) is Valluvan Jeevanandam's primary specialty in the NPI Registry, under taxonomy code 208G00000X. Valluvan Jeevanandam is board certified in thoracic and cardiac surgery by the American Board of Thoracic Surgery. Dmand AI has Valluvan Jeevanandam's licenses on file in 4 states: Illinois, Indiana, Pennsylvania and New York.

Dmand AI lists heart bypass surgery and heart valve surgery among the conditions Valluvan Jeevanandam treats.

CMS data shows 126 Medicare services from Valluvan Jeevanandam across 7 procedure codes in 2024, for 74 Medicare patients. Medicare paid $114,862 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 74 Medicare patients who saw Valluvan Jeevanandam in 2024. The largest group is 65 to 74, with 36 patients. 75% of them have heart failure, and 75% have high blood pressure. Their average risk score is 1.74, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Valluvan Jeevanandam's median patient age at 71, with 40% women.

In 2024, Valluvan Jeevanandam wrote 87 Medicare Part D claims. 68% of them were for generic drugs. CMS names the drug for 79 of them, across 2 drugs with 11 or more claims each, at $208,670 in total drug cost. In 2023, CMS named 24 claims across 1 drug.

Valluvan Jeevanandam accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 33 procedures of coronary artery bypass graft (cabg) by Valluvan Jeevanandam, more than 86% of the clinicians it reports for that procedure.

Dmand AI links 266 papers to Valluvan Jeevanandam, published from 2004 to 2025. 2020 was the busiest year, with 35. The most frequent topics are Heart-Assist Devices, Heart Failure and Heart Transplantation. Valluvan Jeevanandam has published most often in ASAIO J. Valluvan Jeevanandam's most frequent co-authors are Nir Uriel, MD, Gabriel T. Sayer, MD and Takeyoshi Ota.

Dmand AI links Valluvan Jeevanandam to 3 clinical trials. Conditions studied include Heart Failure, Systolic and Heart Failure.

CMS Open Payments shows 418 general payments to Valluvan Jeevanandam from 25 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 83% of the total. Abbott Laboratories paid the most, $152,451.

Dmand AI lists 3 awards for Valluvan Jeevanandam, most recently CMS Stage 1 EHR in 2013.

Valluvan Jeevanandam graduated from Vagelos College of Physicians and Surgeons in 1984.

Valluvan Jeevanandam is in network with 20 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.